Axspa NewsLatest News On Axspa Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease7/9/2025 9:17 AM Key Updates in Axial Spondyloarthritis From EULAR 20257/7/2025 8:50 AM Axial Spondyloarthritis: Low Disease Activity Maintained OK via Remote Monitoring or Patient-Initiated Care7/4/2025 6:25 AM JAK1 Inhibitor Shows Promise for Ankylosing Spondylitis7/1/2025 2:34 AM Early Treatment With Golimumab Shows High Remission Rates in Axial Spondyloarthritis6/29/2025 10:47 PM Do NSAIDs Affect Sacroiliitis Visibility on MRI in Axial Spondyloarthritis?6/23/2025 6:56 AM Sacroiliac MRI Lesions Set Apart axSpA and Other Back Pain6/9/2025 8:52 AM First Classification Criteria for Axial Disease in Juvenile Spondyloarthritis Now Finalized5/27/2025 9:19 AM Depression Poorly Affects axSpA Treatment Response5/19/2025 6:40 AM Revised Axial Spondyloarthritis Classification Criteria Ready for Prime Time5/14/2025 1:54 AM
